{"disease":{"id":"soft-tissue-sarcoma-of-the-extremity","name":"soft tissue sarcoma of the extremity"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03092323","title":"A Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the Extremity","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":126,"lead_sponsor_name":"Sarcoma Alliance for Research through Collaboration","has_results":false},{"nct_id":"NCT06737172","title":"Functional and Structural Outcomes Following Childhood Bone or Soft Tissue Sarcomas of the Lower Extremity","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":18,"lead_sponsor_name":"Technical University of Munich","has_results":false},{"nct_id":"NCT06743958","title":"Prehabilitation in Childhood Soft Tissue or Bone Sarcomas","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":16,"lead_sponsor_name":"Technical University of Munich","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}